Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

15.33 UNCHANGED

Streaming Delayed Price Updated: 4:15 PM EDT, Jun 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 18, 2026

From Schrödinger

Via Business Wire

Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 02, 2026

Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash flow, and valuation.

Via The Motley Fool

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 22, 2026

From Schrödinger

Via Business Wire

Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides ↗

May 05, 2026

Via Chartmill

Schrödinger Inc (NASDAQ:SDGR) Posts Q4 Earnings Beat Amid Strategic Software Model Shift ↗

February 25, 2026

Via Chartmill

Topics Earnings

My Top 3 Biotech Stocks for May 2026 ↗

May 20, 2026

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Schrödinger (SDGR) Q1 2026 Earnings Transcript ↗

May 05, 2026

Schrödinger (SDGR) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Schrödinger Reports First Quarter 2026 Financial Results

May 05, 2026

From Schrödinger

Via Business Wire

Schrödinger to Participate in Upcoming Investor Conferences

May 04, 2026

From Schrödinger

Via Business Wire

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

April 21, 2026

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 17, 2026

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

March 18, 2026

From Schrödinger

Via Business Wire

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

February 25, 2026

From Schrödinger

Via Business Wire

Schrödinger to Participate in Upcoming Investor Conferences

February 24, 2026

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 18, 2026

From Schrödinger

Via Business Wire

The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot

February 17, 2026

As of February 17, 2026, the biotechnology sector is undergoing its most significant structural transformation in decades, a period now widely termed the "Biotechnology Renaissance." Following a...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

February 11, 2026

From Schrödinger

Via Business Wire

AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months

February 06, 2026

In a breakthrough that many are calling the "Penicillin Moment" of the 21st century, researchers at the Massachusetts Institute of Technology, led by bioengineering pioneer James Collins, have...

Via TokenRing AI

Topics Artificial Intelligence

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year...

Via MarketMinute

Topics Artificial Intelligence ETFs Initial Public Offering

From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance

January 12, 2026

In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

January 12, 2026

From Schrödinger

Via Business Wire

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

January 09, 2026

From Schrödinger

Via Business Wire

Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence

January 05, 2026

The biosimulation market was sent into a tailspin in the closing months of 2025 as Certara (Nasdaq:CERT), a global leader in model-informed drug development, saw its market valuation crater by 23%. The...

Via MarketMinute

Topics Earnings

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

December 20, 2025

The famous investor's funds were active buyers in the run-up to the holidays.

Via The Motley Fool

Topics Bonds ETFs

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 17, 2025

From Schrödinger

Via Business Wire

Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture

December 01, 2025

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

Moss Spores Defy the Void: A Tiny Plant’s Giant Leap for Astrobiology and Off-World Ecosystems

November 24, 2025

Recent groundbreaking research has revealed the astonishing resilience of moss spores, with over 80% surviving a nine-month exposure to the brutal conditions on the exterior of the International Space...

Via TokenRing AI

Topics Artificial Intelligence

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Intellectual Property

Schrödinger to Present at Jefferies London Healthcare Conference

November 06, 2025

From Schrödinger

Via Business Wire

Schrödinger Reports Third Quarter 2025 Financial Results

November 05, 2025

From Schrödinger

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.